Browse studies

Find your next paid study

27,270 recruiting studies available now

Enhancing the Organizational Social Context to Improve Viral Suppression and Retention in HIV Care: A Randomized Controlled Trial

Despite the widespread use of effective antiretroviral therapy (ART), the HIV epidemic continues to impact racial and ethnic minority populations disproportion…

HIV/AIDS

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PennsylvaniaNCT06462807

Observational

Transcranial Stimulation Combined With Auditory Training

The goal of this clinical trial is to learn if non-invasive brain stimulation (called transcranial stimulation) can enhance the benefits from auditory training…

Difficulties Understanding Speech in Noise

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston University Charles River CampusNCT06738030

Phase 2

A Randomized Trial of Neratinib, A Pan-ERBB Inhibitor, Alone or in Combination With Palbociclib, a CDK4/6 Inhibitor, in Patients With HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial

This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positi…

Malignant Female Reproductive System NeoplasmMalignant Solid NeoplasmRecurrent Malignant Female Reproductive System Neoplasm+1 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06126276

Phase 1

Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2

An exploratory, randomized, double-blinded, placebo-controlled, two-center clinical trial to determine the maximum tolerated dosage of intravenous tirofiban in…

Aneurysmal Subarachnoid Hemorrhage

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dr David Hasan, M.D.NCT07493577

Paradoxical Tuberculosis Reactions in Patients Without HIV Infection

Background: Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first,…

Tuberculosis

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT04052022

Phase 2

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Disease Phase IIa Open-Label Clinical Trial and Associated Mechanistic Studies

Background: Sjogren disease is an autoimmune disease - that is, a disease that causes the body's immune system to attack its own organs and tissues. Sjogren d…

Sjogren's Syndrome

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Dental and Craniofacial Research (NIDCR)NCT07281456

BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Mortality Prediction

Estimated

~$10 – $750

Actual pay is set by the research site.

Henry Ford Health SystemNCT07769151

Phase 3

A Phase 3, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Participants With Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma

This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in part…

GliomaAstrocytoma, Grade IVIDH1-mutant Glioma+5 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Nuvation Bio Inc.NCT05303519

Phase 2

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People

The investigators recently demonstrated that blockade of Glucagon-Like Peptide-1's (GLP-1) receptor (GLP1R) results in changes in islet function without change…

Type 1 DiabetesType 2 Diabetes

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06976619

ObservationalRemote eligible

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Dyspnea, or breathlessness, is one of the most common and distressing symptoms experienced by patients with advanced lung cancer. The purpose of this multi-sit…

Advanced Lung CancerDyspnea

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06791057

Phase 3

A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy

The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with I…

Chronic Inflammatory Demyelinating Polyneuropathy

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT06290141

Phase 3

Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Nonfunctional Neuroendocrine Neoplasms (REMAIN Trial)

This is a multicenter, randomized, open-label, phase III study comparing standard of care use of somatostatin analogues (SSAs) to standard of care observation …

Neuroendocrine NeoplasmGastroenteropancreatic Neuroendocrine Neoplasm

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Washington University School of MedicineNCT07842172